Professor Gerard Sutton, an Australian ophthalmologist and biotech entrepreneur, envisions a future where curing blindness globally is achievable through cell replication and 3D printing.
Co-founder of Bienco, Sutton reveals a breakthrough product capable of mass-producing natural corneas for transplantation, revolutionizing sight restoration. Traditional cornea transplants, reliant on donors, face limitations, making Bienco’s innovative approach crucial. Their artificial corneas, based on transparent collagen, promise to address the shortage of donor corneas, potentially treating more individuals in need.
Backed by significant funding, it aims to lead bioengineering advancements, offering hope to millions awaiting vision restoration worldwide.